Under construction – not a live service
Sign in
Taking people in AustriaNo phase

Electrical stimulation for arm and hand weakness after stroke

Compares two electrical stimulation methods in adults with arm weakness after stroke.

Plain-language title generated from the registry record
Registry title: Comparison of Four-Channel Functional Electrical Stimulation vs. One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients

Key facts

Where
Hermagor, Linz, and Zirl, AustriaSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT07098572, who can take part

Where in Austria

  • KABEG Gailtal-Klinik LKH HermagorHermagor, AustriaTaking people
  • Kepler Universitätsklinikum LinzLinz, AustriaTaking people
  • Ö. Landeskrankenhaus Hochzirl - Natters, Standort HochzirlZirl, AustriaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
MED-EL Elektromedizinische Geräte GmbH
Trial code
NCT07098572
Record updated
14 August 2026
Original description
This study will compare two treatments that may help participants recover after having suffered from stroke. Persons who experience weakness or paralysis of their arms/hands will be randomly placed in one of two groups. Each receives treatment five times a week for three weeks. One group will be treated with electrostimulation following a cyclic pattern (control treatment), the other group will be treated with electrostimulation triggered by nerve signals (i.e. stimulation starts when they deliberately try to move their arm (investigational treatment). Before and after the three weeks and additionally 12 weeks later, the ability to move the arm and hand will be documented with standardized tests.Read full original descriptionShow less

Efficacy of EMG-triggered Four-Channel Functional Electrical Stimulation vs. Cyclic One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients. A Randomized Controlled Single Blinded Multicenter Study

This study will compare two treatments that may help participants recover after having suffered from stroke. Persons who experience weakness or paralysis of their arms/hands will be randomly placed in one of two groups. Each receives treatment five times a week for three weeks. One group will be treated with electrostimulation following a cyclic pattern (control treatment), the other group will be treated with electrostimulation triggered by nerve signals (i.e. stimulation starts when they deliberately try to move their arm (investigational treatment). Before and after the three weeks and additionally 12 weeks later, the ability to move the arm and hand will be documented with standardized tests.

Inclusion: First-time ischemic stroke with moderate arm paresis (Motricity Index - UE Sum-Score ≥ 40 ≤ 77 points) (Collin \& Wade, 1990); Early to late subacute phase (7 days - 6 months) (Bernhardt et al., 2017); Existing ADL ability before the event (ICF d5 self-care, d6 domestic life, extent of problem ≤1 points) (WHO, 2001); Age ≥18 - 99 years; Signed and dated ICF before the start of any study-specific procedure.

Exclusion: Implanted defibrillators, brain stimulators, pacemakers, medication pumps; Participation in other pharmacological clinical investigations within four weeks prior to enrolment; Therapy-resistant epilepsy; Fever or infectious diseases; Inflammatory or tumorous skin diseases in the stimulation area,; Known allergic reactions to components of the investigational medical device; Lack of compliance with any inclusion criteria; Thromboses or vein inflammations; Severe contractures of the affected extremity; Wounds in the stimulation area; Pregnancy; Unstable psychological status; Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study.

ClinicalTrials.gov NCT07098572